Leading Indian pharmaceutical maker Lupin Limited announced on Thursday that its American subsidiary has gained approval from the US Food and Drugs Administration to market Levonorgestrel and Ethinyl Estradiol tablets, generic equivalent of Teva’s Seasonale Tablets.
The two tablets are a combined oral contraceptive indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception, a company release said on Thursday.
Deccan Herald News now on Telegram - Click here to subscribe
Follow us on Facebook | Twitter | Dailymotion | YouTube
SRK fans make Guinness World Record with iconic pose
Why chronic stress drives craving for 'comfort food'
Messi in Beijing for friendly before Miami move
One giant rubber duck in Hong Kong harbour deflates
Chhattisgarh: Class 10, 12 toppers go on chopper ride
NDTV announces 'higher than industry average' hikes
I Never Loved a Man (the Way I Love You)
Navy shows prowess amid China's Indian Ocean forays
Road accident death rate drops in Kerala due to AI cams
How could AI destroy humanity?